February 4, 2022 Comments Off on New patent for Allergan drug RESTASIS MULTIDOSE Posted in: Patent Added Annual Drug Patent Expirations for RESTASIS+MULTIDOSE Restasis Multidose is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents…
The post New patent for Allergan drug RESTASIS MULTIDOSE appe…
February 3, 2022 Comments Off on New patent for Sun Pharma drug DRIZALMA SPRINKLE Posted in: Patent Added Annual Drug Patent Expirations for DRIZALMA+SPRINKLE Drizalma Sprinkle is a drug marketed by Sun Pharma Global and is included in one NDA. It is available from one supplier. There are…
The post New patent for Sun Pharma drug DRIZALMA SPRINKLE appeared …